Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Mao LinShuzhen LiangXiaohua WangYinqing LiangMingjie ZhangJi-Bing ChenLizhi NiuKecheng Xu

Published in: Journal of cancer research and clinical oncology (2017)

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy significantly increased median PFS and median OS in stage III pancreatic cancer and extended the median OS of stage IV pancreatic cancer. Multiple allogeneic natural killer cells infusion was associated with better prognosis to stage III pancreatic cancer.

Keyphrases

stem cell transplantation
bone marrow
natural killer cells
single cell
hematopoietic stem cell
cell therapy
minimally invasive
low dose
stem cells
radiofrequency ablation
squamous cell carcinoma
locally advanced
nk cells
rectal cancer